Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for XPR. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: XPR is a Strong Sell candidate.
XPR price ended at $0.002393 on 星期六, after rising 11.89%
On Feb 07, 2026 00:00, the price of XPR rose by 11.89%, climbing from $0.002087 to $0.002393 with 24h trading volume reaching $1.9M XPR.